Liver scarring can pave the way to cancer down the line. A new blood test in development might help doctors spot it.

Oncoguard® Liver blood test delivers six times greater sensitivity for very early-stage hepatocellular carcinoma (HCC) versus standard of care. These findings will be presented as late-breaking data ...

Liver cancer is hard to treat and deadly if it's diagnosed late, which is why early detection is so important. Tamar Taddei is part of a Department of Veterans Affairs study that is the largest ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

Liver cancer rates are projected to nearly double by 2050, but experts say up to 60% of cases could be prevented. Key steps include tackling viral hepatitis, reducing alcohol use, and managing obesity ...

A new update from the American Gastroenterological Association (AGA) urges stronger prevention efforts and better ...

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat ...

New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and ...

For the first time, a simple blood draw has the potential to identify dozens of cancers at an early stage, when treatment is more effective and less costly.

The rising incidence of liver cancer across the globe is becoming an alarming public health concern. Once considered ...

ALTUS study is the largest prospective trial of a blood test for liver cancer surveillance in the United States, reflecting the racial and ethnic diversity of high-risk groups These findings will be ...